Status:
COMPLETED
Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Postmenopause
Eligibility:
FEMALE
35-70 years
Brief Summary
The purpose of this study is to determine bioequivalence and bioavailability of four different Premarin/MPA test formulations versus the current formulation for Prempro.
Eligibility Criteria
Inclusion
- Healthy postmenopausal women aged 35 to 70 years
- Nonsmoker or smoker of less than 10 cigarettes per day
Exclusion
- History or presence of clotting disorders
- History or presence of cancer
- Presence of HIV, hepatitis B or hepatitis C
- History of drug or alcohol abuse
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00380887
Start Date
June 1 2005
Last Update
September 27 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.